Clinical and research tests for C0752121 - Genetic Testing Registry (GTR)

Page 2 of 4

Results: 21 to 40 of 62

Tests names and labs	Conditions	Genes, analytes, and microbes	Methods
Genetic Test for Spinocerebellar Ataxias - SCA1, SCA2, SCA3, SCA6, SCA7, SCA17 and DRPLA CGPP - Center for Predictive and Preventive Genetics IBMC - Institute for Cell and Molecular Biology Portugal	7	7	D Deletion/duplication analysis
Genetic Test for Spinocerebellar Ataxia Type 2 - SCA2 CGPP - Center for Predictive and Preventive Genetics IBMC - Institute for Cell and Molecular Biology Portugal	1	1	D Deletion/duplication analysis
Spinocerebellar Ataxia (SCA) Type 2 Duzen Laboratories Duzen BBAGUAS Turkey	1	1	T Targeted variant analysis
SCA Panel (Type 1,2,3,6,7) Duzen Laboratories Duzen BBAGUAS Turkey	4	5	T Targeted variant analysis
Spinocerebellar Ataxia Type 2 Repeat Analysis GeneDx United States	1	1	T Targeted variant analysis
Spinocerebellar Ataxia Repeat Expansion Analysis GeneDx United States	6	6	T Targeted variant analysis
Spinocerebellar Ataxia Expansion Panel Greenwood Genetic Center Diagnostic Laboratories Greenwood Genetic Center United States	5	5	E Sequence analysis of select exons
Spinocerebellar Ataxia Type 2 Expansion Analysis Greenwood Genetic Center Diagnostic Laboratories Greenwood Genetic Center United States	1	1	E Sequence analysis of select exons
SCA2 (ATXN2) Genetic Testing (Repeat expansion) MNG Laboratories (Medical Neurogenetics, LLC.) United States	2	1	E Sequence analysis of select exons
Spinocerebellar ataxia: Full gene sequencing panel CEN4GEN Institute for Genomics and Molecular Diagnostics Canada	38	37	I Microsatellite instability testing (MSI) C Sequence analysis of the entire coding region
Frontotemporal dementia and/or Amyotrophic Lateral Sclerosis: Full gene sequencing panel CEN4GEN Institute for Genomics and Molecular Diagnostics Canada	30	30	I Microsatellite instability testing (MSI) C Sequence analysis of the entire coding region
Comprehensive Ataxia Repeat Expansion Panel (SCA 1, 2, 3, 6, 7, 8, 10, 12, 17, 36, DRPLA & FRDA) MNG Laboratories (Medical Neurogenetics, LLC.) United States	12	12	T Targeted variant analysis
Ataxia Repeat Expansion Analysis Fulgent Genetics United States	19	15	T Targeted variant analysis
ATXN2 (Spinocerebellar Ataxia Type 2) Repeat Expansion Fulgent Genetics United States	1	1	T Targeted variant analysis
Ataxia Related Disorders , Panel Massive Sequencing (NGS) 35 Genes Reference Laboratory Genetics Spain	37	34	C Sequence analysis of the entire coding region
Spinocerebellar ataxia type 2 Molecular Genetics Laboratory North York General Hospital Canada	1	1	T Targeted variant analysis
Comprehensive Spinocerebellar Ataxia Repeat Expansion Panel (SCA 1, 2, 3, 6, 7, 8, 10, 12, 17, 36 & DRPLA) MNG Laboratories (Medical Neurogenetics, LLC.) United States	11	11	T Targeted variant analysis
SPINOCEREBELLAR ATAXIA (AUTOSOMAL DOMINANT) (SCAs) Laboratorio de Genetica Clinica SL Spain	18	19	C Sequence analysis of the entire coding region T Targeted variant analysis
Ataxia, Complete Dominant Evaluation Athena Diagnostics Inc United States	31	25	C Sequence analysis of the entire coding region T Targeted variant analysis
Ataxia, Comprehensive Evaluation Athena Diagnostics Inc United States	44	42	D Deletion/duplication analysis C Sequence analysis of the entire coding region T Targeted variant analysis

<< First < Prev

Page 2 of 4

Next >Last >>

Results: 21 to 40 of 62

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.

Filters

Test type

Test purpose

Test method

Molecular Genetics

Test service

Laboratory certification

Specimen type

Laboratory location

Other countries

Results: 21 to 40 of 62

Results: 21 to 40 of 62